Welcome to our dedicated page for Northrop Grumman SEC filings (Ticker: NOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
An insider has filed a notice to sell 20,000 shares of common stock, to be executed through Fidelity Brokerage Services LLC on the NYSE around February 6, 2026. The filing lists an aggregate market value of 14,176,423.20 for these shares, with 141,921,621 shares of the class outstanding.
The shares to be sold were acquired through restricted stock vesting from the issuer on February 13, 2022, February 15, 2022, and February 14, 2024 as compensation. Over the prior three months, the same seller disposed of 7,000 shares of common stock on January 5, 2026 for 4,200,000.00 and a further 3,000 shares on January 6, 2026 for 1,845,000.00.
Northrop Grumman director Mark A. Welsh III reported open-market sales of 95 shares of common stock on February 2, 2026. The sales were made in multiple small trades under a Rule 10b5-1 trading plan adopted on August 23, 2025.
The reported transactions occurred at weighted average prices ranging from $676.14 to $689.31 per share. After these sales, Welsh directly beneficially owns 4,203 shares of Northrop Grumman common stock.
Northrop Grumman Corporation outlines its 2025 business, scale and risks as a leading global aerospace and defense technology company focused on U.S. and international security customers, especially the U.S. Department of War and intelligence community.
The company operates through four segments — Aeronautics Systems, Defense Systems, Mission Systems and Space Systems — covering aircraft, missiles, space systems, sensors, cyber and command-and-control solutions, with a mix of open and restricted programs.
In 2025, total sales were $ in millions: U.S. Government $35,183, International $5,990, Other $781, Total $41,954, split about evenly between cost-type and fixed-price contracts, and U.S. government sales represented 84% of revenue. Backlog reached $95.7 billion, up from $91.5 billion a year earlier, indicating multi‑year revenue visibility.
As of June 30, 2025, non‑affiliate market value of common stock was about $71.5 billion, and as of January 22, 2026 there were 141,921,621 shares outstanding. The company employed about 95,000 people at year‑end 2025 after hiring roughly 7,500 in 2025, and discusses extensive risk factors spanning dependence on U.S. defense budgets, cost estimation and contract risk, macroeconomic and supply chain pressures, cybersecurity, environmental obligations and evolving regulations.
Northrop Grumman Corporation filed a current report to note that it has released its financial results for the fourth quarter and full year ended December 31, 2025. On January 27, 2026, the company issued an earnings release titled “Northrop Grumman Reports Fourth Quarter and Full-Year 2025 Financial Results,” which is included as Exhibit 99 to this report. The filing identifies this earnings release as furnished information on results of operations and financial condition, rather than detailed financial statements within the report itself.
Northrop Grumman Corporation’s Chief Financial Officer, John Greene, filed an initial ownership report stating that he beneficially owns no company securities. The Form 3 shows that as of 01/07/2026, he held 0 shares of common stock directly and reported no derivative securities such as options or warrants. A remark reiterates that no securities are beneficially owned, and a power of attorney is noted as an exhibit, indicating that the filing was submitted on his behalf by an attorney-in-fact.
Northrop Grumman (NOC) Chair, CEO and President Kathy J. Warden reported two open-market stock sales under a pre-arranged Rule 10b5-1 trading plan. On January 5, 2026, she sold 7,000 shares of Northrop Grumman common stock at $600 per share. On January 6, 2026, she sold an additional 3,000 shares at $615 per share. These transactions were executed pursuant to a Rule 10b5-1 plan adopted on September 2, 2025. After the reported sales, she directly beneficially owns 191,602.4 shares of Northrop Grumman common stock.
NOC shareholder Kathy J. Warden filed a notice to sell 3,000 shares of common stock with an aggregate market value of $1,845,000 through Fidelity Brokerage Services LLC, with an approximate sale date of January 6, 2026 on the NYSE.
The filing notes that there were 142,720,067 shares of common stock outstanding. The 3,000 shares to be sold were acquired on February 14, 2024 through restricted stock vesting from the issuer as compensation, with payment also dated February 14, 2024. Over the past three months, Warden previously sold 7,000 common shares on January 5, 2026 for gross proceeds of $4,200,000.
Northrop Grumman Corporation director reports routine equity compensation activity. On 12/31/2025, the director acquired 64 shares of Northrop Grumman common stock at $570.21 per share through deferral into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this transaction, the director beneficially owned 2,257 shares in the stock unit account. The filing notes that dividends credited on shares in this account are exempt from Section 16 and were not required to be reported.
Northrop Grumman reported an equity transaction by a company director. On 12/31/2025, the director acquired 81 shares of Northrop Grumman common stock at $570.21 per share. These shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction that is exempt under Rule 16b-3.
Following this transaction, the director beneficially owned 10,963 shares of common stock in the stock unit account, which includes dividends credited under the plan. Dividends earned on these stock units were exempt from Section 16 reporting and therefore were not required to be reported as separate transactions.
Northrop Grumman insider filed a notice to sell company stock under Rule 144. The filing covers 7,000 shares of common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 4,200,000.00. The notice lists 142,720,067 shares outstanding of the same class of stock.
The shares planned for sale come from restricted stock vesting awards received from the issuer as compensation. The insider acquired 4,621 shares on 02/14/2024 and 2,379 shares on 02/16/2024, both labeled as compensation. The approximate date of sale is given as 01/05/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about Northrop Grumman’s operations.